Publications by authors named "Fenna Visser"

Objective: To compare the association of the severity categories of the 2001-National Institutes of Health (NIH), the 2018-NIH and the 2019-Jensen bronchopulmonary dysplasia (BPD) definitions with neurodevelopmental and respiratory outcomes at 2 and 5 years' corrected age (CA), and several BPD risk factors.

Design: Single-centre historical cohort study with retrospective data collection.

Setting: Infants born between 2009 and 2015 at the Amsterdam University Medical Centers, location Amsterdam Medical Center.

View Article and Find Full Text PDF

Introduction: The objective of this study was to identify risk factors for neurodevelopmental impairment (NDI) at 2- and 5-years corrected age (CA) in a cohort of preterm infants with established bronchopulmonary dysplasia (BPD).

Methods: This single-center retrospective cohort study included infants born between 2009 and 2016 at a gestational age (GA) <30 weeks with moderate or severe BPD at 36 weeks' postmenstrual age. Perinatal characteristics, (social) demographics, and comorbidities were collected from the electronic patient records.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to investigate how the severity of bronchopulmonary dysplasia (BPD) affects the risk of neurodevelopmental impairment (NDI) at ages 2 and 5 years, and whether this relationship changes over time.
  • Involving 790 infants born before 30 weeks of gestation, the findings showed that those with varying degrees of BPD had a significantly higher risk of NDI compared to infants without BPD, with a marked increase in NDI risk from age 2 to age 5.
  • The research concluded that greater BPD severity correlates with higher NDI risk at both ages, and while the incidence of NDI increased from 2 to 5 years,
View Article and Find Full Text PDF

Unlabelled: To establish the validity of biochemical markers of metabolic bone disease (MBD) in preterm infants.

Conclusion: There is insufficient evidence that any of the frequently used serum measurements are valid biochemical markers of MBD in preterm infants. Increased urinary calcium concentration may be a valid biochemical marker, but more research is necessary to confirm this.

View Article and Find Full Text PDF